We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

    Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite...

    Shaosen Zhang, **nyi **ao, ... Chen Wu in Signal Transduction and Targeted Therapy
    Article Open access 19 June 2024
  2. MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma

    Metadherin (MTDH) is a well-established oncogene in various cancers including Hepatocellular Carcinoma (HCC). However, the precise mechanism through...

    Chen **, Dong Han-hua, ... Zhang Bi-xiang in Oncogene
    Article 17 November 2022
  3. Letter to the Editor Regarding Article “Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset”

    The cited article reports on a convolutional neural network trained to predict response to neoadjuvant chemotherapy from pre-treatment breast MRI...

    Article 30 April 2024
  4. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer

    Purpose

    The optimal time to initiation of adjuvant chemotherapy (TTAC) for triple negative breast cancer (TNBC) patients is unclear. This study...

    Maria Eleni Hatzipanagiotou, Miriam Pigerl, ... Stephan Seitz in Breast Cancer Research and Treatment
    Article Open access 19 January 2024
  5. Integrating a Disease-Focused Tumor Board as a Delivery-of-Care Model to Expedite Treatment Initiation for Patients With Liver Malignancies

    Background

    Patients with hepatobiliary malignancies are especially vulnerable to treatment delays. This study sought to evaluate the impact of...

    Jasmina Ehab, Benjamin Powers, ... Daniel A. Anaya in Annals of Surgical Oncology
    Article 20 October 2021
  6. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

    Microorganisms, including bacteria, viruses, fungi, and other eukaryotes, play critical roles in human health. An altered microbiome can be...

    Li Yang, Aitian Li, ... Yi Zhang in Signal Transduction and Targeted Therapy
    Article Open access 16 January 2023
  7. Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma

    Background

    Lenvatinib, a multiple receptor tyrosine kinase inhibitor, might exert antitumor effects via tumor immune modulation. However, changes in...

    Masami Yamauchi, Atsushi Ono, ... Shiro Oka in Communications Medicine
    Article Open access 25 October 2023
  8. Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment

    Neutrophils exert either pro- or anti-tumor activities. However, few studies have focused on neutrophils at the tumor initiation stage. In this...

    Mengyuan Kou, Wenting Lu, ... Yongli Yu in Cancer Immunology, Immunotherapy
    Article 20 April 2023
  9. Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia

    Purpose

    The majority of breast cancer patients are diagnosed with early-stage estrogen receptor (ER) positive disease. Despite effective treatments...

    Lindsay J. Collin, Jade Jones, ... Lauren E. McCullough in Breast Cancer Research and Treatment
    Article Open access 22 March 2024
  10. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression

    Immune checkpoint blockade (ICB) necessitates a thorough understanding of intricate cellular interactions within the tumor microenvironment (TME)....

    Yanyan Zhang, Charles Wang, Jian Jian Li in Experimental Hematology & Oncology
    Article Open access 01 July 2024
  11. The role of tumor-associated macrophages in tumor immune evasion

    Background

    Tumor growth is closely linked to the activities of various cells in the tumor microenvironment (TME), particularly immune cells. During...

    Ruizhe Huang, Ting Kang, Siyu Chen in Journal of Cancer Research and Clinical Oncology
    Article Open access 07 May 2024
  12. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma

    Background

    Esophagectomy is the main treatment for esophageal squamous cell carcinoma (ESCC), and patients with histopathologically negative margins...

    Dan Gao, Bang-guo Tan, ... Tian-wu Chen in Cancer Imaging
    Article Open access 19 January 2024
  13. Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation

    Background

    We examined the impact of early (0–4 weeks after discharge) versus late (> 4–8 weeks after discharge) initiation of adjuvant chemotherapy...

    Jakob Kirkegård, Morten Ladekarl, ... Frank Mortensen in Annals of Surgical Oncology
    Article Open access 01 November 2023
  14. Forming cytoplasmic stress granules PURα suppresses mRNA translation initiation of IGFBP3 to promote esophageal squamous cell carcinoma progression

    Esophageal squamous cell carcinoma (ESCC) is one of the most fatal malignancies worldwide. Recently, our group identified purine-rich element binding...

    Lusong Tian, **ufeng **e, ... **aohang Zhao in Oncogene
    Article Open access 09 August 2022
  15. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era

    Guidelines recommend rasburicase for high-risk patients to prevent tumor lysis syndrome (TLS). However, little information is available on the...

    Yumiko Toda, Masahiro Ashizawa, ... Yoshinobu Kanda in International Journal of Hematology
    Article 05 April 2024
  16. Tumor-associated characteristics and immune dysregulation in nasopharyngeal carcinoma under the regulation of m7G-related tumor microenvironment cells

    Background

    Nasopharyngeal carcinoma (NPC) is a type of malignant tumor with high morbidity. Aberrant levels of N7-methylguanosine (m7G) are closely...

    Zhen Long, **aochen Li, ... Jie Liu in World Journal of Surgical Oncology
    Article Open access 25 June 2024
  17. Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease

    Background

    Low socioeconomic status is associated with disadvantages in health outcomes and delivery of medical care in patients with Inflammatory...

    Sofie Ronja Petersen, Nathalie Fogh Rasmussen, ... Vibeke Andersen in Wiener klinische Wochenschrift
    Article Open access 24 May 2024
  18. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression

    Crosstalk between cancer cells and the immune microenvironment is determinant for liver cancer progression. A tumor subpopulation called liver cancer...

    Yue Ma, Hongwei Lv, ... Wen Yang in Frontiers of Medicine
    Article 11 April 2024
  19. Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database

    Oral anticoagulants (OACs) are recommended for patients with atrial fibrillation (AFib) having CHA 2 DS 2 -VASc score ≥ 2. However, the benefits of OAC...

    Bang Truong, Lori Hornsby, ... **g**g Qian in Journal of Thrombosis and Thrombolysis
    Article Open access 20 March 2024
  20. Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

    There is strong evidence that chemotherapy can induce tumor necrosis which can be exploited for the targeted delivery of immuno-oncology agents into...

    S. Elizabeth Franks, Ginette S. Santiago-Sanchez, ... James W. Hodge in Cancer Immunology, Immunotherapy
    Article Open access 11 May 2023
Did you find what you were looking for? Share feedback.